FDA Drugs recall ·
TESTO-200, Testosterone Cypionate Inj recall
- Recall number
- D-0531-2025
- Date
- (initiated May 30, 2025)
- Company / brand
- Advanced Pharmaceutical Technology, Inc.
132 S Central Ave, Elmsford, NY, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 26 vials
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523. NDC 57377-200-01
Why was it recalled?
Marketed Without an Approved NDA/ANDA
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot P-24-1; Exp. 02/28/2027
Distribution
NY, NJ
States: New Jersey New York
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0531-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.